Full name : Anderson Matt S
First name : Matt S
Mail : Merck & Co., Inc. Rahway NJ 07065
Zip Code :
City :
Country : USA
Email : matt_anderson@merck.com
Phone :
Fax :
Website :
Directory :
| Title : Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects - Anderson_2015_Antivir.Ther_20_397 |
| Author(s) : Anderson MS , Gilmartin J , Cilissen C , De Lepeleire I , Van Bortel L , Dockendorf MF , Tetteh E , Ancona JK , Liu R , Guo Y , Wagner JA , Butterton JR |
| Ref : Antivir Ther , 20 :397 , 2015 |
| Abstract : Anderson_2015_Antivir.Ther_20_397 |
| ESTHER : Anderson_2015_Antivir.Ther_20_397 |
| PubMedSearch : Anderson_2015_Antivir.Ther_20_397 |
| PubMedID: 25470746 |
| Title : Odanacatib, a selective cathepsin K inhibitor, demonstrates comparable pharmacodynamics and pharmacokinetics in older men and postmenopausal women - Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| Author(s) : Anderson MS , Gendrano IN , Liu C , Jeffers S , Mahon C , Mehta A , Mostoller K , Zajic S , Morris D , Lee J , Stoch SA |
| Ref : J Clinical Endocrinology Metab , 99 :552 , 2014 |
| Abstract : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| ESTHER : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedSearch : Anderson_2014_J.Clin.Endocrinol.Metab_99_552 |
| PubMedID: 24276460 |